The First-in-Human use of our peptide SenoMune-0257 which reverses aging and fights cancer.

 

Proud to announce the First-in-Human use of our peptide SenoMune-0257 which reverses aging and fights cancer. https://t.co/yCIWLnL62C

— Dr. Thomas Ichim (@exosome) November 2, 2026